ATYs306Q6fE

63
70. Wang J, Bai Y, Li N, Ye W, Zhang M, Greene SB, Tao Y, Chen Y, Wehrens XH, Martin
JF. Pitx2-microRNA pathway that delimits sinoatrial node development and
inhibits predisposition to atrial fibrillation. Proc Natl Acad Sci USA. 2014;111:
9181–6.
71. Husser D, Adams V, Piorkowski C, Hindricks G, Bollmann A. Chromosome 4q25
variants and atrial fibrillation recurrence after catheter ablation. J Am Coll
Cardiol. 2010;55:747–53.
72. Parvez B, Shoemaker MB, Muhammad R, Richardson R, Jiang L, Blair MA, Roden
DM, Darbar D. Common genetic polymorphism at 4q25 locus predicts at-rial
fibrillation recurrence after successful cardioversion. Heart Rhythm. 2013;10:
849–55.
73. Benjamin Shoemaker M, Muhammad R, Parvez B, White BW, Streur M, Song Y,
Stubblefield T, Kucera G, Blair M, Rytlewski J, Parvathaneni S, Nagarakanti R,
Saavedra P, Ellis CR, Patrick Whalen S, Roden DM, Darbar RD. Common atrial
fibrillation risk alleles at 4q25 predict recurrence after catheter-based atrial
fibril-lation ablation. Heart Rhythm. 2013;10:394–400.
74. Parvez B, Vaglio J, Rowan S, Muhammad R, Kucera G, Stubblefield T, Carter S,
Roden D, Darbar D. Symptomatic response to antiarrhythmic drug therapy is
modulated by a common single nucleotide polymorphism in atrial fibrillation.
J Am Coll Cardiol. 2012;60:539–45.
75. Kirchhof P, Sipido KR, Cowie MR, Eschenhagen T, Fox KA, Katus H, Schroeder S,
Schunkert H, Priori S, ESC CRT R&D and European Affairs Work Shop on Personalized
Medicine. The continuum of personalized cardiovascular medicine:
a position paper of the European Society of Cardiology. Eur Heart J. 2014;35: 3250–7.
76. Kirchhof P, Breithardt G, Aliot E, Al Khatib S, Apostolakis S, Auricchio A, Bailleul
C, Bax J, Benninger G, Blomstrom-Lundqvist C, Boersma L, Boriani G, Brandes A,
Brown H, Brueckmann M, Calkins H, Casadei B, Clemens A, Crijns H, Derwand R,
Dobrev D, Ezekowitz M, Fetsch T, Gerth A, Gillis A, Gulizia M, Hack G, Haegeli L,
Hatem S, Georg Hausler K, Heidbuchel H, Hernandez-Brichis J, Jais P, Kappenberger
L, Kautzner J, Kim S, Kuck KH, Lane D, Leute A, Lewalter T, Meyer R, Mont L, Moses
G, Mueller M, Munzel F, Nabauer M, Nielsen JC, Oeff M, Oto A, Pieske B, Pisters R,
Potpara T, Rasmussen L, Ravens U, Reiffel J, Richard-Lordereau I, Schafer H,
Schotten U, Stegink W, Stein K, Steinbeck G, Szumowski L, Tavazzi L, Themistoclakis
S, Thomitzek K, Van Gelder IC, von Stritzky B, Vincent A, Werring D, Willems S,
Lip GY, Camm AJ. Personalized management of atrial fibrillation: Proceedings
from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm
Association consensus conference. Europace. 2013;15:1540–56.
77. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ,
Ellinor PT, Gollob M, Hamilton R, Hershberger RE, Judge DP, Le Marec H, McKenna
WJ, Schulze-Bahr E, Semsarian C, Towbin JA, Watkins H, Wilde A, Wolpert C,
Zipes DP, Heart Rhythm Society, European Heart Rhythm Associ-ation. HRS/EHRA
expert consensus statement on the state of genetic testing for the channelopathies
and cardiomyopathies: this document was developed as a partnership between
the Heart Rhythm Society (HRS) and the European Heart Rhythm Association
(EHRA). Europace. 2011;13:1077–109.
78. Anne W, Willems R, Roskams T, Sergeant P, Herijgers P, Holemans P, Ector H,
Heidbuchel H. Matrix metalloproteinases and atrial remodeling in patients with
mitral valve disease and atrial fibrillation. Cardiovasc Res. 2005;67:655–66.
79. Chimenti C, Russo MA, Carpi A, Frustaci A. Histological substrate of human atrial
fibrillation. Biomed Pharmacother. 2010;64:177–83.
80. Nguyen BL, Fishbein MC, Chen LS, Chen PS, Masroor S. Histopathological substrate
for chronic atrial fibrillation in humans. Heart Rhythm. 2009;6:454–60.
81. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological
substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation.
1997; 96:1180–4.
82. Venteclef N, Guglielmi V, Balse E, Gaborit B, Cotillard A, Atassi F, Amour J,
Leprince P, Dutour A, Clement K, Hatem SN. Human epicardial adipose tissue
induces fibrosis of the atrial myocardium through the secretion of adipofibrokines.
Eur Heart J. 2013;36:795–805a.
83. Rocken C, Peters B, Juenemann G, Saeger W, Klein HU, Huth C, Roessner A, Goette
A. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation.
Circulation. 2002;106:2091–7.
84. Schotten U, Ausma J, Stellbrink C, Sabatschus I, Vogel M, Frechen D, Schoendube
F, Hanrath P, Allessie MA. Cellular mechanisms of depressed atrial contractility in
patients with chronic atrial fibrillation. Circulation. 2001;103:691–8.
85. Allessie MA, de Groot NM, Houben RP, Schotten U, Boersma E, Smeets JL, Crijns
HJ. Electropathological substrate of long-standing persistent atrial fibrilla-tion in
patients with structural heart disease: longitudinal dissociation. Circ Arrhythm
Electrophysiol. 2010;3:606–15.
86. Spach MS, Josephson ME. Initiating reentry: the role of nonuniform anisotropy in
small circuits. J Cardiovasc Electrophysiol. 1994;5:182–209.
87. Shinagawa K, Shi YF, Tardif JC, Leung TK, Nattel S. Dynamic nature of atrial fibrillation
substrate during development and reversal of heart failure in dogs.
Circulation. 2002;105:2672–8.
88. Lim HS, Willoughby SR, Schultz C, Gan C, Alasady M, Lau DH, Leong DP, Brooks
AG, Young GD, Kistler PM, Kalman JM, Worthley MI, Sanders P. Effect of atrial
fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am
Coll Cardiol. 2013;61:852–60.
89. Hijazi Z, Oldgren J, Siegbahn A, Granger CB, Wallentin L. Biomarkers in atrial fibrillation:
a clinical review. Eur Heart J. 2013;34:1475–80.
90. Xu J, Cui G, Esmailian F, Plunkett M, Marelli D, Ardehali A, Odim J, Laks H, Sen L.
Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation.
Circulation. 2004;109:363–8.
91. Gramley F, Lorenzen J, Plisiene J, Rakauskas M, Benetis R, Schmid M, Autschbach
R, Knackstedt C, Schimpf T, Mischke K, Gressner A, Hanrath P, Kelm M, Schauerte
P. Decreased plasminogen activator inhibitor and tissue me-talloproteinase
inhibitor expression may promote increased metalloproteinase activity with
increasing duration of human atrial fibrillation. J Cardiovasc Electrophy-siol.
2007;18:1076–82.
92. Hatem SN, Sanders P. Epicardial adipose tissue and atrial fibrillation. Cardiovasc
Res. 2014;102:205–13.
93. Leone O, Boriani G, Chiappini B, Pacini D, Cenacchi G, Martin Suarez S, Rapezzi C,
Bacchi Reggiani ML, Marinelli G. Amyloid deposition as a cause of atrial remodelling
in persistent valvular atrial fibrillation. Eur Heart J. 2004;25:1237–41.
94. Dobrev D, Friedrich A, Voigt N, Jost N, Wettwer E, Christ T, Knaut M, Ravens U. The
G protein-gated potassium current I(K,ACh) is constitutively active in pa-tients
with chronic atrial fibrillation. Circulation. 2005;112:3697–706.
95. Van Wagoner DR, Pond AL, Lamorgese M, Rossie SS, McCarthy PM, Nerbonne JM.
Atrial L-type Ca2+ currents and human atrial fibrillation. Circ Res. 1999;85:
428–36.
96. Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of
atrial fibrillation: a translational appraisal. Physiol Rev. 2011;91:265–325.
97. Voigt N, Heijman J, Wang Q, Chiang DY, Li N, Karck M, Wehrens XH, Nattel S,
Dobrev D. Cellular and molecular mechanisms of atrial arrhythmogenesis in patients
with paroxysmal atrial fibrillation. Circulation. 2014;129:145–56.
98. Voigt N, Li N, Wang Q, Wang W, Trafford AW, Abu-Taha I, Sun Q, Wieland T,
Ravens U, Nattel S, Wehrens XH, Dobrev D. Enhanced sarcoplasmic reticulum
Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations
in patients with chronic atrial fibrillation. Circulation. 2012;125:
2059–70.
99. Polontchouk L, Haefliger JA, Ebelt B, Schaefer T, Stuhlmann D, Mehlhorn U, Kuhn-
Regnier F, De Vivie ER, Dhein S. Effects of chronic atrial fibrillation on gap
junction distribution in human and rat atria. J Am Coll Cardiol. 2001;38:883–91.
100. Aime-Sempe C, Folliguet T, Rucker-Martin C, Krajewska M, Krajewska S,
Heimburger M, Aubier M, Mercadier JJ, Reed JC, Hatem SN. Myocardial cell death
in fibrillating and dilated human right atria. J Am Coll Cardiol. 1999;34:1577–86.
101. Spach MS, Heidlage JF, Barr RC, Dolber PC. Cell size and communication: role in
structural and electrical development and remodeling of the heart. Heart
Rhythm. 2004;1:500–15.
102. Skalidis EI, Hamilos MI, Karalis IK, Chlouverakis G, Kochiadakis GE, Vardas PE.
Iso-lated atrial microvascular dysfunction in patients with lone recurrent atrial
fibril-lation. J Am Coll Cardiol. 2008;51:2053–7.
103. Barretto AC, Mady C, Nussbacher A, Ianni BM, Oliveira SA, Jatene A, Ramires JA.
Atrial fibrillation in endomyocardial fibrosis is a marker of worse prognosis. Int J
Cardiol. 1998;67:19–25.
104. Levy S. Factors predisposing to the development of atrial fibrillation. Pacing Clin
Electrophysiol. 1997;20:2670–4.
105. Chen PS, Chen LS, Fishbein MC, Lin SF, Nattel S. Role of the autonomic nervous
system in atrial fibrillation: pathophysiology and therapy. Circ Res. 2014;114:
1500–15.
106. Christ T, Rozmaritsa N, Engel A, Berk E, Knaut M, Metzner K, Canteras M, Ravens
U, Kaumann A. Arrhythmias, elicited by catecholamines and serotonin, vanish in
human chronic atrial fibrillation. Proc Natl Acad Sci USA. 2014;111:11193–8.
107. Greiser M, Kerfant BG, Williams GS, Voigt N, Harks E, Dibb KM, Giese A, Meszaros
J, Verheule S, Ravens U, Allessie MA, Gammie JS, van der Velden J, Lederer WJ,
Dobrev D, Schotten U. Tachycardia-induced silencing of subcellular Ca2+
signaling in atrial myocytes. J Clin Invest. 2014;124:4759–72.
108. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le
Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by
ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–66.
109. Patterson E, Jackman WM, Beckman KJ, Lazzara R, Lockwood D, Scherlag BJ, Wu
R, Po S. Spontaneous pulmonary vein firing in man: relationship to tachycardiapause
early afterdepolarizations and triggered arrhythmia in canine pulmonary
veins in vitro. J Cardiovasc Electrophysiol. 2007;18:1067–75.
110. Atienza F, Almendral J, Moreno J, Vaidyanathan R, Talkachou A, Kalifa J, Arenal A,
Villacastin JP, Torrecilla EG, Sanchez A, Ploutz-Snyder R, Jalife J, Berenfeld O. Activation
of inward rectifier potassium channels accelerates atrial fibrillation in
hu-mans: evidence for a reentrant mechanism. Circulation. 2006;114:2434–42.
111. Mandapati R, Skanes A, Chen J, Berenfeld O, Jalife J. Stable microreentrant sources
as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation.
2000;101:194–9.
112. Sahadevan J, Ryu K, Peltz L, Khrestian CM, Stewart RW, Markowitz AH, Waldo AL.
Epicardial mapping of chronic atrial fibrillation in patients: preliminary
observations. Circulation. 2004;110:3293–9.
113. Sanders P, Nalliah CJ, Dubois R, Takahashi Y, Hocini M, Rotter M, Rostock T, Sacher
F, Hsu LF, Jonsson A, O’Neill MD, Jais P, Haissaguerre M. Frequency map-ping of
the pulmonary veins in paroxysmal versus permanent atrial fibrillation.
J Cardiovasc Electrophysiol. 2006;17:965–72.
114. Moe GK, Abildskov JA. Atrial fibrillation as a self-sustaining arrhythmia independent
of focal discharge. Am Heart J. 1959;58:59–70.
115. Cox JL, Canavan TE, Schuessler RB, Cain ME, Lindsay BD, Stone C, Smith PK, Corr
PB, Boineau JP. The surgical treatment of atrial fibrillation. II. Intraoperative
electrophysiologic mapping and description of the electrophysiologic basis of atrial
flutter and atrial fibrillation. J Thorac Cardiovasc Surg. 1991;101:406–26.
116. Na rayan SM, Krummen DE, Shivkumar K, Clopton P, Rappel WJ, Miller JM. Treatment
of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional
Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor
Modulation) trial. J Am Coll Cardiol. 2012;60:628–36.
117. Haissaguerre M, Hocini M, Denis A, Shah AJ, Komatsu Y, Yamashita S, Daly M,
Amraoui S, Zellerhoff S, Picat MQ, Quotb A, Jesel L, Lim H, Ploux S, Bordachar P,
Attuel G, Meillet V, Ritter P, Derval N, Sacher F, Bernus O, Cochet H, Jais P, Dubois
R. Driver domains in persistent atrial fibrillation. Circulation. 2014;130:530–8.